Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroreport ; 12(3): 511-4, 2001 Mar 05.
Article in English | MEDLINE | ID: mdl-11234755

ABSTRACT

The therapeutic use of BAL (2,3-dimercaptopropanol) as treatment for poisoning has been halted by data suggesting serious neurotoxicity. This article is a report on the effects of BAL and other dithiols, DMSA (meso-2,3-dimercaptosuccinic acid) and DMPS (2,3-dimercaptopropane-1-sulfonic acid), on [3H]glutamate release and uptake by rat brain synaptosomes and [3H]glutamate uptake by synaptic vesicles. BAL (100 microM) inhibited glutamate uptake (30%) and stimulated its basal release (30%) in synaptosomes, without affecting K+-stimulated release. BAL also inhibited glutamate uptake by synaptic vesicles (up to 60%). DMPS and DMSA (100 microM) had no significant effects on these parameters. The data reported here provide some evidence of glutamate involvement in BAL-induced neurotoxicity by demonstrating direct effects of BAL on glutamatergic system modulation.


Subject(s)
Chelating Agents/toxicity , Dimercaprol/toxicity , Glutamic Acid/pharmacokinetics , Synaptosomes/drug effects , Synaptosomes/metabolism , Animals , Biological Transport/drug effects , Brain/metabolism , In Vitro Techniques , Male , Potassium/pharmacology , Rats , Rats, Wistar , Succimer/toxicity , Tritium , Unithiol/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...